Back to search

Article

Therapeutic Interruption of T Cell Development Generates High-Affinity T Cells That Escape Exhaustion and Improve Cancer Immunotherapy

2022-01-21

Abstract excerpt

<h4>SUMMARY</h4> Availability of effective anti-tumor T cells is limited by cancer immunoediting, which depletes neoantigens, and central tolerance, which eliminates developing T cells with high-affinity T cell receptors (TCRs) against tumor self-antigens. Remaining tumor-reactive T cells are often exhausted after immune checkpoint blockade (ICB). Whether endogenous T cells with high- affinity TCRs against tumor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa270093-884d-5dbd-85e1-d060b549fc54
DOI
10.1101/2022.01.19.476935
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutic Interruption of T Cell Development Generates High-Affinity T Cells That Escape Exhaustion and Improve Cancer ImmunotherapyDOI 10.1101/2022.01.19.476935
Select a neighboring publication to make it the new centre.